Related Experiment Videos
Effect of rokitamycin on human polymorphonuclear leukocyte chemotaxis
1Division of Infectious Diseases, Regional Hospital, Varese, Italy.
International Journal of Tissue Reactions
|January 1, 1989
Summary
Rokitamycin showed an in vitro inhibitory effect on human polymorphonuclear leukocyte (PMNL) migration at high concentrations. However, in vivo studies found no significant changes in PMNL chemotaxis after rokitamycin ingestion.
Area of Science:
- Immunology
- Pharmacology
Background:
- Human polymorphonuclear leukocytes (PMNLs) are crucial immune cells involved in inflammatory responses.
- Understanding the impact of antibiotics on immune cell function is vital for clinical applications.
Purpose of the Study:
- To investigate the in vitro and in vivo effects of rokitamycin on human PMNL chemotaxis.
- To determine if rokitamycin modulates immune cell migration.
Main Methods:
- In vitro chemotaxis assays were performed using human PMNLs exposed to varying concentrations of rokitamycin.
- In vivo studies involved assessing PMNL chemotaxis in healthy individuals before and after oral administration of rokitamycin.
Main Results:
- Rokitamycin significantly diminished PMNL migration in vitro at a concentration of 20 micrograms/ml.
- Lower concentrations of rokitamycin did not exhibit significant effects on PMNL migration in vitro.
- No significant alterations in PMNL chemotaxis were observed in vivo following rokitamycin ingestion.
Conclusions:
- Rokitamycin exhibits concentration-dependent inhibitory effects on human PMNL chemotaxis in vitro.
- The in vivo administration of rokitamycin does not appear to significantly impact PMNL chemotaxis in healthy individuals.